ÉTUDE PRODIGE 18-UNICANCER-Accord22 - Recrutement terminé/clôturé

Title

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Coordonateur

BENNOUNA J

Co-Coordonateur

HEBBAR M

Promoteur

UNICANCER (UCGI)

Localisation

Cancer Colorectal Métastatique

Phase

IIR

NOMBRE DE PATIENTS ATTENDU

132

Statut

Recrutement terminé/clôturé

CONTACT

c-dumasbonnetain@unicancer.fr